Article Details

ImaginAb Executes New License and Supply Agreement for CD8 ImmunoPET Technology ...

Retrieved on: 2022-11-22 20:42:02

Tags for this article:

Click the tags to see associated articles and topics

ImaginAb Executes New License and Supply Agreement for CD8 ImmunoPET Technology .... View article details on hiswai:

Excerpt

ImaginAb Inc., a global biotechnology company developing 89Zr crefmirlimab ... to re-activate the immune system within the liver and pancreas.

Article found on: www.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up